> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Grand Jury Indicts Freedom Pharma Owner, Employees
- URL: https://www.fdaweb.com/grand-jury-indicts-freedom-pharma-owner-employees/
- Published: 2016-07-26T12:00:00.000Z
- Updated: 2026-09-14T21:18:15.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5136278

A federal grand jury has returned an indictment charging two Florida residents and one North Carolina resident with manufacturing and distributing performance-enhancing drugs in violation of FDA regulations. **William Bagwell** (Petersburg, FL), **Cole Leggett** (Clearwater, FL) and **Robert Nicholson-Gould** (Lexington, NC) allegedly conspired to manufacture and distribute various unapproved prescription drugs to customers throughout the U.S. Bagwell was owner of Freedom Pharma and the other two worked at the company, which was not registered with the agency as a drug manufacturer. “The drugs, which include, dehydrochloromethyltestosterone, drostanolone enanthate, exemestane, methandienone, nandrolone decanoate, oxandrolone, oxymetholone, sildenafil, stanozolol, tadalafil, tamoxifen citrate, testosterone, and trenbolone, were misbranded and introduced into interstate commerce,” a Justice Department [release](http://www.fda.gov/ICECI/CriminalInvestigations/ucm513146.htm?ref=fdaweb.com) says.  

The defendants were each charged with one count of conspiracy to violate the Federal Food, Drug, and Cosmetic Act, and one count of conspiracy to violate the Controlled Substances Act. They each face up to five years in prison and a fine up to $250,000 for the conspiracy to violate the Federal Food, Drug, and Cosmetic Act charge; and up to ten years in prison and a fine up to $250,000 for the conspiracy to violation the Controlled Substances Act charge.